373 results
Thumbnail

D3.387 - Assessment of safety of cryopreserved mesenchymal stem cells in the treatment of atopic dermatitis

Thumbnail

D3.388 - Association of HLA and cytokine production as risk factors for prostate cancer

Thumbnail

D3.389 - The Role Of Metabolic Endotoxemia In The Development Of Systemic Inflammation In Patients With Type 1 And Type 2 Diabetes Mellitus

Thumbnail

D3.390 - Lipopolysaccharide-Binding Protein And sCd14 In Patients With Type 1 Diabetes Mellitus And Diabetic Nephropathy

Thumbnail

D3.391 - The Effect of Bicarbonate Mineral Water on Endotoxemia Markers in Patients with Type 1 Diabetes Mellitus

Thumbnail

D3.392 - Associations Between Markers Of Endotoxin-Binding Systems And Vasoactive Agents In Patients With Rheumatoid Arthritis

Thumbnail

D3.393 - Immunological Profiling of the Kras-Driven Microenvironment in a Murine Model of Endometriosis

Thumbnail

D3.394 - Assessment of safety and tolerability of mesenchymal stem cells and tolerogenic dendritic cells as a therapy for type 1 diabetes

Thumbnail

D3.395 - Analysis of single cell multiome data (transcriptomics + ATAC) from human nasal polyp mast cells

Thumbnail

D3.396 - A new B-cell epitope profiling of glutathione S-transferase allergens supports mite-specific cross-reactivity within different species

Thumbnail

D3.397 - MOG Antibody–Associated Bilateral Optic Neuritis in a Child Following Mycoplasma Infection

Thumbnail

D3.402 - Evaluation of Apigenin's Anti-Inflammatory and Wound Healing Effects Using Atopic Dermatitis Cell Culture Model

Thumbnail

D3.403 - Protein Profiling of CAR-Engineered NK92-Derived Exosomes Using Western Blot

Thumbnail

D3.406 - Novel bone materials selectively modulate the human immune response to favor remodeling over acute inflammation

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.443 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Switch Cohort

Thumbnail

D3.446 - PROTECT Phase I/IIa Clinical Trial Demonstrated Strong Correlation Between Humoral Immune Response and Dose of VLP Peanut in Healthy Participants

Thumbnail

D3.451 - Long-term follow-up of ASA therapy after desensitization in patients with chronic rhinosinusitis with nasal polyps indicates high rate of treatment discontinuation

Thumbnail

D3.457 - Does the Way We Ask Matter? Comparing Self- and Interviewer-Administered RQLQ in Allergic Rhinoconjunctivitis